Deerfield Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Deerfield Management’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-33,117	Closed	-$331K	–	158
2021 Q2	$331K	Sell	33,117 -340,000	-91%	-$3.78M	0.01%	142
2021 Q1	$4.37M	Sell	373,117 -563,174	-60%	-$9.47M	0.09%	124
2020 Q4	$33.4M	Hold	936,291	–	–	0.66%	46
2020 Q3	$12.9M	Buy	936,291 +122	+0%	+$1.82K	0.32%	77
2020 Q2	$15.4M	Hold	936,169	–	–	0.45%	68
2020 Q1	$7.96M	Buy	+936,169	New	+$13.1M	0.25%	76

Other funds holding LUMO

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Deerfield Management's LUMO Position: Q3 2021 in Review

Deerfield Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2021, closing a stake of 33,117 shares — an estimated $331K sold.

Deerfield Management first reported a position in LUMO in Q1 2020 and held it in 6 quarters. The position peaked at $33.4M in Q4 2020. 37 funds tracked by Wall St. Rank hold LUMO as of Q3 2021.

Deerfield Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Deerfield Management sold 33,117 Lumos Pharma, Inc. Common Stock shares in Q3 2021, an estimated $331K.
Deerfield Management first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2020 and held it in 6 quarters.
Deerfield Management's Lumos Pharma, Inc. Common Stock position peaked at $33.4M in Q4 2020.
37 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2021.

Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.